Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.2

(-2.9%)

Total Liabilities Summary of Genetics Generation Advancement Corp.

  • Genetics Generation Advancement Corp.'s latest annual total liabilities in 2023 was 164.9 Million TWD , up 52.41% from previous year.
  • Genetics Generation Advancement Corp.'s latest quarterly total liabilities in 2024 Q2 was 178.3 Million TWD , up 33.84% from previous quarter.
  • Genetics Generation Advancement Corp. reported annual total liabilities of 108.2 Million TWD in 2022, up 2.02% from previous year.
  • Genetics Generation Advancement Corp. reported annual total liabilities of 106.06 Million TWD in 2021, up 9.11% from previous year.
  • Genetics Generation Advancement Corp. reported quarterly total liabilities of 178.3 Million TWD for 2024 Q2, up 33.84% from previous quarter.
  • Genetics Generation Advancement Corp. reported quarterly total liabilities of 164.9 Million TWD for 2023 FY, up 52.41% from previous quarter.

Annual Total Liabilities Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Total Liabilities of Genetics Generation Advancement Corp. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 164.9 Million TWD 52.41%
2022 108.2 Million TWD 2.02%
2021 106.06 Million TWD 9.11%
2020 97.2 Million TWD 1.3%
2019 95.95 Million TWD 0.0%

Peer Total Liabilities Comparison of Genetics Generation Advancement Corp.

Name Total Liabilities Total Liabilities Difference
BIONET Corp. 626.46 Million TWD 73.677%
DIVA Laboratories, Ltd. 210.93 Million TWD 21.819%
Welgene Biotech Co.,Ltd. 247.89 Million TWD 33.477%
Puriblood Medical Co., Ltd. 84.35 Million TWD -95.501%
TFBS Bioscience Inc. 187.43 Million TWD 12.02%